Sun Pharma expects high single-digit top-line growth in FY23 Ruchika Sharma1 Jun 2022 5:30 AM GMT"R&D investments are expected to be between 7-8 per cent of sales next year," Shanghvi noted.
Sun Pharma reports consolidated net profit of Rs 1,444 crore in Q1 Medical Dialogues Bureau1 Aug 2021 4:00 AM GMT"We witnessed a strong Q1, driven by a combination of robust core business growth, low base and some sale of Covid products," Sun Pharmaceutical...
No plans to get into vaccine production: Sun Pharma Ruchika Sharma14 Jun 2021 5:00 AM GMTNew Delhi: Sun Pharma has no immediate plans to enter into vaccine production as getting into the vertical would require an altogether different...
SPARC appoints Anil Raghavan as new CEO, Dilip Shanghvi resigns as MD Ruchika Sharma26 May 2021 8:18 AM GMTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Tuesday said Dilip Shanghvi has resigned as managing director of the company.Shanghvi...
SPARC issues warrants worth Rs 1,200 crore to promoter Dilip Shanghvi, others Ruchika Sharma14 May 2021 7:01 AM GMTNew Delhi: Sun Pharma Advanced Research Company (SPARC) plans to raise up to Rs 1,200 crore by way of issuing warrants to the company''s promoter...
Sun Pharma, Dilip Shanghvi, officials pay over Rs 2 crore charges to settle alleged violation case with SEBI Ruchika Sharma12 Feb 2021 7:13 AM GMTNew Delhi: Sun Pharmaceutical Industries Ltd and its senior officials, including Managing Director Dilip Shanghvi, on Thursday settled with regulator...
Sun Pharma aims to protect supply chain, preserve cash amid COVID challenges Ruchika Sharma20 July 2020 6:30 AM GMTShanghvi said that the company is also looking at supply chain protection, ensuring optimum utilisation of its factories and working closely with...
